Views & Analysis A sea-change for pharma? Pandemic commercial models and laun... Sarah Rickwood looks at how COVID-19 is changing pharma’s commercial models and launch strategies.
Partner Content Partner Content Launch Excellence 2020 In the past year, the competition in biosimilars and complex generics has complicated the launch landscape.
Views & Analysis Launch excellence in a disrupted world The accelerating speed of change within the pharmaceutical launch environment raises considerable challenges for launch excellence, as companies grapple with a complex and ever-changing wor
News Shire looks to eye drug as sales beat forecasts Company reports better than expected full year figures.